Penn Vet | CCC Clinical Trials
Contact
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
610-444-5800
Directions
Ryan Hospital Philadelphia, PA
Emergencies:
215-746-8911
Appointments:
215-746-8387
Directions

Comparison of the efficacy & impact on suppressor cells of CHOP vs. LOPP chemotherapy in canine T-cell lymphoma

CHOP vs. LOPP chemotherapy for T-cell Lymphoma

cancer active active lymphoma lymph node chemotherapy cancer

Clinical evaluation of propranolol and doxorubicin for the treatment of splenic hemangiosarcoma in the dog

In this trial, we will be evaluating Propranolol’s effect on survival time and quality of life when given in combination with the standard chemotherapy treatment.

cancer center splenic HSA splenic hemangiosarcoma spleen propranolol PPL HSA hemangiosarcoma chemotherapy cancer active cancer active

Soft Tissue Sarcoma & Mammary Carcinoma - Photoacoustic System for Identifying Tumor Edges (PSITE)

cancer active tumor removal tumor soft tissue sarcoma mammary carcinoma cancer center cancer active

Study of two oral medications in treament of canine brain tumors

Evaluating safety and anti-cancer activity of oral PAC-1 used with hydroxyurea for canine meningioma

cancer active seizure meningioma brain tumor active

Use of Near-infrared Imaging in Surgical Accuracy for Feline Soft-Tissue Sarcomas

Penn Vet is conducting a study to determine if near-infrared imaging can improve the surgeon’s ability to see cancer and cancer margins during surgery to remove feline soft tissue sarcomas.

cancer active ryan surgery infrared imaging feline soft tissue sarcoma david holt active

Trial of ALVAC® IL-2 Treatment in Cats with Feline Fibrosarcoma

Clinical trial evaluating surgery in combination with immunotherapy for cats with fibrosarcoma

cancer active VAS vaccine tumor surgery sarcoma FSA cancer active

Re-directed Autologous T cell Therapy for B cell lymphoma or B Cell Leukemia

Immune cells (known as T cells) are taken from the peripheral blood, stimulated, expanded and genetically modified in the laboratory to express a surface receptor that recognizes B cells

Mason Active immunotherapy comprehensive cancer care canine lymphoma canine cancer cancer center cancer active cancer b-cell malignancies B-cell lymphoma active